Med4Cast S.A. announced that it has received CHF 12,500 at par value on March 29, 2022. The transition included participation from new investor, Katalysen Ventures AB (publ) who owns 20% stake of the company as a part of the transaction.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
17.9 SEK | -0.56% | -0.56% | +35.61% |
Apr. 15 | Katalysen Ventures Portfolio Company Files for Bankruptcy | MT |
Mar. 14 | Katalysen Ventures Unit Buys Germany's Smart4Diagnostics | MT |
1st Jan change | Capi. | |
---|---|---|
+35.61% | 11.3M | |
+31.41% | 12.02B | |
+14.40% | 3.06B | |
+2.96% | 1.42B | |
+1.15% | 616M | |
+35.79% | 577M | |
-10.84% | 579M | |
-4.17% | 492M | |
+33.85% | 488M | |
+3.90% | 304M |
- Stock Market
- Equities
- KAV Stock
- News Katalysen Ventures AB
- Med4Cast S.A. announced that it has received funding from Katalysen Ventures AB